• 2-Bromo-1,4-Naphthalenedione promotes CD8(+) T cell expansion and limits Th1/Th17 to mitigate experimental autoimmune encephalomyelitis
• A Disease Hidden in Plain Sight: Pathways and Mechanisms of Neurological Complications of Post-acute Sequelae of COVID-19 (NC-PASC)
• A pathologically expanded, clonal lineage of IL-21-producing CD4+ T cells drives inflammatory neuropathy
• A retrospective analysis of the clinical profile and factors associated with mortality and poor hospital outcomes in adult Guillain-Barre syndrome patients
• Acute Motor Conduction Block Neuropathy After Initiation of Omalizumab: Case Report and Literature Review for Possible Causality
• Acute-onset chronic inflammatory demyelinating polyneuropathy following AstraZeneca COVID-19 vaccine: a case report
• An immuno-DOT diagnostic assay for autoimmune nodopathy
• An Uncommon Association: HLA-B27 Positivity in Conjunction With Pernicious Anemia - A Case Report and Literature Review
• An Unusual Case of Neurofascin 186 Neuropathy
• Animal models of immune-mediated demyelinating polyneuropathies
• Anti-IgLON5 disease: A case with intestinal obstruction and peripheral neuropathy
• Anti-Purkinje Cell Cytoplasmic Antibody Type 2-Associated Autoimmune Cerebellar Degeneration in Children: A Different Phenotype From Adults
• Anti-sulfatide antibody associated GBS with headache and abdominal pain: a case report
• Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)
• Antibodies in Autoimmune Neuropathies: What to Test, How to Test, Why to Test
• Antigen-specific immunotherapy via delivery of tolerogenic dendritic cells for multiple sclerosis
• Autoimmune Encephalitis
• Autoimmune glial fibrillary acidic protein astrocytopathy
• Autoimmune nodopathy with anti-contactin 1 antibody characterized by cerebellar dysarthria: a case report and literature review
• Autoimmunity in Syndromes of Orthostatic Intolerance: An Updated Review
• Bioinformatics analysis of the potential biomarkers of Multiple Sclerosis and Guillain-Barré syndrome
• Brachial plexopathy as a complication of axillary artery aneurysm in a case of Takayasu arteritis
• Case report and brief literature review: possible association of secukinumab with Guillain-Barré syndrome in psoriasis
• CD4⁺ T cell mitochondrial genotype in Multiple Sclerosis: a cross-sectional and longitudinal analysis
• Chronic Inflammatory Demyelinating Polyneuropathy Following Lumbar Spine Surgery in a Patient With Sarcoidosis
• Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
• Clinical and serological insights into paraneoplastic brachial amyotrophic diplegia
• Clinical characteristics of patients with autoimmune nodopathy with anti-neurofascin155 antibodies
• Clinical presentation and symptomatology of Guillain-Barré syndrome: A literature review
• Co-existence of ANCA-associated vasculitides with immune-mediated diseases: a single-center observational study
• Coexistence of Guillain-Barre Syndrome and Subacute Combined Degeneration of the Spinal Cord Due to Autoimmune Gastritis: A Case Report and Literature Review
• Corneal neuropathic pain: a review to inform clinical practice
• Cutting edge of diagnosis and treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) based on the EAN/PNS guideline 2021
• Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review
• Decrypting the multifaceted peripheral neuropathy based on molecular pathology and therapeutics: a comprehensive review
• Development of a major histocompatibility complex class II conditional knockout mouse to study cell-specific and time-dependent adaptive immune responses in peripheral nerves
• Diabetic cheiroarthropathy in uncontrolled type 2 diabetes with positive anti-nuclear antibodies: a case report from Sudan
• Different Patterns of Autoantibody Secretion by Peripheral Blood Mononuclear Cells in Autoimmune Nodopathies
• Distribution characteristics of antinuclear antibodies in Guillain-Barré syndrome and its relationship with disease severity
• Elevated concentration of beta2-microglobulin among patients with carpal tunnel syndrome in the course of primary Sjögren syndrome - a prospective observational study on 50 patients
• Engineering Mycoplasma pneumoniae to bypass the association with Guillain-Barré syndrome
• Excitatory amino acid transporter supports inflammatory macrophage responses
• Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine
• Extracellular Vesicles in Multiple Sclerosis: Their Significance in the Development and Possible Applications as Therapeutic Agents and Biomarkers
• Focal inflammatory neuropathies
• Foreign substance injection for esthetic purposes associated with delayed unilateral sciatic nerve impairment: A surgical case report
• Frequency and severity of autonomic dysfunction assessed by objective hemodynamic responses and patient-reported symptoms in individuals with myasthenia gravis
• Genetic association between gut microbiota and the risk of Guillain-Barré syndrome
• Guillain-Barre syndrome following scrub typhus: a case report and literature review
• High serum prevalence of autoreactive IgG antibodies against peripheral nerve structures in patients with neurological post-COVID-19 vaccination syndrome
• HLA-DR3 ~ DQ2 associates with sensory neuropathy in paraneoplastic neurological syndromes with Hu antibodies
• How to Perform Autoantibody Testing for Autoimmune and Inflammatory Diseases of Peripheral Nerves and Muscles
• HSCT for systemic autoimmune diseases with neurologic involvement
• Human stem cell-derived neurons and astrocytes to detect novel auto-reactive IgG response in immune-mediated neurological diseases
• Immune dysregulation in chronic inflammatory demyelinating polyneuropathy
• Immune-Related Peripheral Neuropathy Associated with Immune Checkpoint Inhibitors: Case Report and Review of Literature
• Immunoglobulin G4-related disease manifesting as peripheral neuropathy: A rare clinical symptom due to rare autoimmune disease
• Impaired autonomic function and somatosensory disturbance in patients with treated autoimmune thyroiditis
• Long-term follow-up of relapse and remission of CIDP in a Chinese cohort
• Lower extremity peripheral nerve block for total knee arthroplasty in a patient with chronic inflammatory demyelinating polyneuropathy: A case report
• Management of chronic inflammatory demyelinating polyradiculoneuropathy
• Mercury Induced Autoimmunity: A Case of CASPR2/LGI1 Autoimmune Encephalitis in a 14-Month-old
• Modern Perspectives on Peripheral Neuropathology
• Molecular dissection of an immunodominant epitope in K(v)1.2-exclusive autoimmunity
• Molecular mimicry between Plasmodium sp and Guillain-Barre syndrome antigens
• Navigating the complexity of pain in psoriatic arthritis and axial spondyloarthritis
• Neurological and Psychiatric Clinical Manifestations of Sjögren Syndrome
• Neuromyotonia
• Neuronal toxicity of monoclonal antibodies (mAbs): an analysis of post-marketing reports from FDA Adverse Event Reporting System (FAERS) safety database
• P2X7 receptor antagonists modulate experimental autoimmune neuritis via regulation of NLRP3 inflammasome activation and Th17 and Th1 cell differentiation
• Parasympathetic neurons derived from human pluripotent stem cells model human diseases and development
• Peripheral nervous system immune-related adverse events due to checkpoint inhibition
• Peripheral Neuropathy and Muscle Disorders as Immune-Related Adverse Events
• Peripheral neuropathy associated with severe glial fibrillary acidic protein (GFAP) astrocytopathy: a case report
• Polyneuropathy in systemic sclerosis: exploring the causes and biomarkers
• Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies
• PRESenting a Challenge: Posterior Reversible Encephalopathy Syndrome in Pediatric Patients With Guillain-Barré Syndrome: A Case Series and Review of Literature
• Preventing long-term disability in CIDP: the role of timely diagnosis and treatment monitoring in a multicenter CIDP cohort
• Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT)
• Reduced serum IgG galactosylation is associated with increased inflammation during relapses of neuromyelitis optica spectrum disorders
• Rituximab Therapy for Immune-Mediated Neurological Diseases: Our Experience at a Tertiary Care Centre
• Safety of Anti-Reelin Therapeutic Approaches for Chronic Inflammatory Diseases
• Semiquantitative assessment of preganglionic nerves for chronic immune-mediated neuropathies using brachial plexus magnetic resonance imaging
• Siponimod treatment response shows partial BDNF dependency in multiple sclerosis models
• Small fiber neuropathy in children, adolescents, and young adults with chronic orthostatic intolerance and postural orthostatic tachycardia syndrome: A retrospective study
• Spontaneous human CD8 T cell and autoimmune encephalomyelitis-induced CD4/CD8 T cell lesions in the brain and spinal cord of HLA-DRB1*15-positive multiple sclerosis humanized immune system mice
• Subacute combined degeneration of the spinal cord with cerebellar lesions: A case report
• Superacute onset of Guillain-Barré syndrome after elective spinal surgery: A case report and literature review
• Superior oblique palsy as the initial manifestation of anti-contactin-1 IgG4 autoimmune nodopathy: A case report
• Symptom progression in neuromyelitis optica spectrum disorder from ataxia through syncope to neuropathic pain: A case report
• The brain microvasculature is a primary mediator of interferon-α neurotoxicity in human cerebral interferonopathies
• The Impact of COVID-19 on the Guillain-Barré Syndrome Incidence
• The multiple roles of nerve biopsy in the diagnosis and prognosis of suspected immune neuropathies
• The role of antibodies in small fiber neuropathy: a review of currently available evidence
• The spectrum of anti-GQ1B antibody syndrome: beyond Miller Fisher syndrome and Bickerstaff brainstem encephalitis
• Therapeutic Approach to Autoimmune Neurologic Disorders
• Understanding exosomes: Part 2-Emerging leaders in regenerative medicine
• Utilization of Peripheral Neuropathology Tests
• VX-509 (Decernotinib)-modified tolerogenic dendritic cells alleviate experimental autoimmune neuritis by promoting Th17/Treg rebalance
• Ways to think about vasculitic neuropathy